This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

Dr Paul Beaulieu, Ph.D. – Professor ESG-UQAM (Montreal)

Paul Beaulieu

Paul Beaulieu is professor of business strategy at the School of Management Sciences of the University of Quebec in Montreal (Canada). He is also visiting professor and researcher on business and development strategies of financial systems at the Luxembourg School of Finance. He is the author of five books in management.

Professor Beaulieu teaches and conducts research on business ecosystems development and strategic foresight. His research focuses on issues related to institutional capacity evaluation and development at the organisation level and within complex systems. He serves frequently as advisor for governments on strategic improvement of competitive capacities at regional, national and industry levels.

In 1996-1997 he was deputy minister for the Government of Quebec and responsible for policies and economic development strategies in the Ministry of Industry, Commerce, Science and Technology. During that period he was responsible of major public funds dedicated to the development of the new economy in Quebec. Besides being member of the board for many public institutions, he was part of the steering committee for the National Summit on socio-economic development of Quebec.

Previously he has been associate professor of strategic analysis at the Canadian Center for Management Development which is mandated for the training and management development of deputy ministers in Canada. He was also president of the Canadian international consultancy firm Setym Technologies. In the past decade he has performed executive development seminars in China, Egypt, Lebanon, Mali, Cuba, Brazil, and Japan.

Professor Beaulieu is chairman of the boards of BioInnovation, a Canadian venture capital fund dedicated to life sciences business opportunities, and also of the Quebec Centre for Technology Transfer in Biotechnology (CQVB).



Stay connected:
Get connected
Share your comments
More on Deloitte Luxembourg
Learn about our site

Recently published